What is prostate cancer doing before any symptoms arrive to warn you
Prostate cancer is the most commonly diagnosed malignancy in men and one of the most complex to navigate because of the wide spectrum of disease it represents, ranging from slow-growing forms that may never cause harm in a person’s lifetime to aggressive variants that can metastasize and become life-threatening within years of development. This spectrum […]
What kidney cancer looks like before most people notice
Kidney cancer often develops without obvious symptoms, making awareness of the risk factors and early warning signs a critical part of long-term health. The kidneys do their work quietly. They filter waste from the blood, balance the body’s fluid levels and help regulate blood pressure, all without much fanfare. That same […]
Liver cancer: what doctors actually do depends on the stage
Liver cancer diagnosis doesn’t come with a single treatment path. What a patient receives depends on several converging factors — how far the disease has progressed, the size and number of tumors, and how well the liver itself is functioning. Two patients with the same diagnosis can end up with entirely different treatment plans, and […]
Breast cancer study reveals a timing factor worth paying attention to
Breast cancer treatment has long followed a familiar sequence. Surgery comes first, usually a lumpectomy or mastectomy, and radiation follows. For decades that order has been treated as standard. A study out of the Moffitt Cancer Center in Tampa, Florida, published in 2017, raised a question that the oncology field hadn’t fully confronted: what if […]
Lung cancer screening in India and the AI tools changing it
Lung cancer kills more people globally than any other cancer, accounting for 1.8 million deaths each year. In India, the situation is particularly grim. The country recorded 81,742 new lung cancer cases in 2022 and 75,031 deaths in the same year. The survival rate sits at approximately 5%, compared to roughly 20% in Western nations. […]
New hope for treating triple negative breast cancer is finally within reach
Triple negative breast cancer occupies a particularly difficult corner of oncology. It accounts for roughly 10 to 15 percent of all breast cancer diagnoses, yet it behaves more aggressively than most other forms of the disease, tends to grow quickly and historically has offered fewer treatment options. The latest advances in cancer research are now […]
Colorectal cancer treatment may be heading in a fundamentally different direction
Colorectal cancer is treated successfully in many patients, but it comes back in roughly 30% of cases after surgical intervention. That recurrence rate has been one of the most persistent challenges in oncology, and it is largely driven by a specific type of cell that conventional therapies struggle to eliminate. New research is pointing toward […]
Why do some of the most deadliest cancers receive comparatively less funding from the NIH?
Cancer research funding from the National Institutes of Health does not proportionally reflect which diseases are most deadly, according to a new study that examined federal investment across nine major tumor types in the United States. The findings raise pointed questions about whether current priorities align with clinical urgency or whether historical patterns and advocacy […]
Injectable immunotherapy shrinks precancerous mouth lesions and spares patients from surgery
Injectable immunotherapy delivered directly into precancerous lesions in the mouth significantly reduced their size and helped the majority of patients avoid surgery, according to results from a phase I clinical trial presented at the American Association for Cancer Research Annual Meeting in April 2026. Roughly 5 percent of the general population carries precancerous lesions in […]
Breast cancer detection has 4 findings that explain why early screening changes everything
Breast cancer detection is the medical conversation that most women know they should be having more seriously than they are. The recommendations exist, the technology exists, and the evidence for why early detection changes outcomes is among the most well-established in all of oncology. And yet screening rates remain below where public health researchers believe […]